Evidence map›Paper›PMID 30315103›Full record

ArticleThe Journal of biological chemistry2018

Comprehensive analysis of

Guozhang Zou, Martina Kosikova, Su-Ryun Kim, Shweta Kotian, Wells W Wu, Rongfong Shen, David N Powers, Cyrus Agarabi, Hang Xie, Tongzhong Ju

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Single-Dose Intranasal Combination Panebolavirus Vaccine.The Journal of infectious diseases · 2023
    Article
  5. An etanercept O-glycovariant with enhanced potency.Molecular therapy. Methods & clinical development · 2022
    Article
  6. Article
  7. The Journal of biological chemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Guozhang ZouFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and.
Martina Kosikovathe Office of Vaccines Research and Review and.
Su-Ryun KimFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and.
Shweta KotianFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and.
Wells W WuFacility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993.
Rongfong ShenFacility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993.
David N PowersFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and.
Cyrus AgarabiFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and.
Hang Xiethe Office of Vaccines Research and Review and hang.xie@fda.hhs.gov.
Tongzhong JuFrom the Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993 and tongzhong.ju@fda.hhs.gov.
Center for Drug Evaluation and Research · USCenter for Biologics Evaluation and Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza viruses cause contagious respiratory infections, resulting in significant economic burdens to communities. Production of influenza-specific Igs, specifically IgGs, is one of the major protective immune mechanisms against influenza viruses. In humans,

Indexed as

FerretsAcetylglucosamineAnimalsGlycosylationHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin GInfluenza A virusMaleOrthomyxoviridae InfectionsPolysaccharidesAcetylglucosamineHemagglutinin Glycoproteins, Influenza VirusImmunoglobulin GPolysaccharidesferretfucosylationglycosylationIgGimmunityinfluenzaMSN-linked glycosylationUPLCvaccine development

Identifiers

PMID30315103
PMCPMC6302183
OpenAlexW2897301107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.